This inventor holds 4 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2001-2003.
Company Filing History:
Years Active: 2001-2003
Title: The Innovations of Kurt-Jürgen Hoffmann
Introduction
Kurt-Jürgen Hoffmann is a notable inventor based in Kullavik, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmias. With a total of 4 patents to his name, Hoffmann's work has had a meaningful impact on medical science.
Latest Patents
Hoffmann's latest patents include innovative compounds such as Oxabispidine compounds and Bispidine compounds, both of which are useful in the treatment of cardiac arrhythmias. These inventions showcase his dedication to improving healthcare and patient outcomes.
Career Highlights
Hoffmann is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Hoffmann has worked alongside talented colleagues such as Gert Strandlund and Annika Björe. These collaborations have fostered an environment of innovation and creativity, leading to the development of new therapeutic solutions.
Conclusion
Kurt-Jürgen Hoffmann's contributions to the field of pharmaceuticals, particularly in cardiac treatment, highlight his role as a significant inventor. His work continues to influence the medical community and improve patient care.